A Study in Healthy Volunteers to Assess Immune Response to Multiple Injections of Filgrastim Hospira or Neupogen Reference Product.
Clinical trial NCT02923791 · COMPLETED
Trial details
- NCT number
- NCT02923791
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2017-01-01
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.